Hepatocellular carcinoma continues to pose a diagnostic challenge, particularly in the setting of underlying pathomorphological changes in the liver due to cirrhosis, steatosis, or steatohepatitis.

On 12 Feb 2025, Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

China: A recent study published in the Annals of Hepatology has emphasized the influence of age on hepatocellular carcinoma ...

Peer support workers, known as champions, help some of the patients with some of their challenges.

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...

in treatment naïve patients with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC). These data are being presented at the 2025 ASCO Gastrointestinal Cancers Symposium ...

Each guideline was checked for the following topics: prevention, screening and surveillance, diagnosis, clinical staging, curative treatment, trans-arterial therapies and systemic therapies.

HCC screening and surveillance protocols. Figure 1. Liquid biopsy for early detection of hepatocellular carcinoma: current state for clinical applications, strengths, and limitations. Images have been ...

Correspondence to Dr Ruben Hernaez, Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas, USA; ruben.hernaez{at}bcm.edu The authors also proposed a treatment algorithm based on ...

E-mail: [email protected] Cancer Immunol Res 2025;13:162–70 Current address for T. Kobayashi: Department of Neurosurgery, Tokyo Women's Medical University, Tokyo, Japan.

7 Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China Objective Hepatocellular carcinoma (HCC) is heterogeneous, especially in multifocal tumours, ...